Home / Inspections / 1268964

FDA Inspection 1268964 — Chongqing Carelife Pharmaceutical Co., Ltd.

Chongqing Carelife Pharmaceutical Co., Ltd. — FEI 3011903543

The FDA completed an inspection of Chongqing Carelife Pharmaceutical Co., Ltd. on March 28, 2025 in Chongqing. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 28, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chongqing (China)

Facility

Other inspections at this facility

  • 1098996 (NAI Fri Jul 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1035442 (OAI Thu Nov 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 970028 (OAI Thu May 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 851858 (VAI Fri Oct 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 684797 (VAI Fri Jul 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources